Pulse Pharma... DCGI approval for Nano Vitamin D3
Hyderabad: Hyderabad-based Pulse Pharmaceuticals announced that it has received approval from the Drugs Controller General of India (DCGI) for its nano-carrier entrapped Vitamin D3 oral medication. Speaking here on Thursday, the company's founder and MD, KV Rambabu, stated that the regulatory body granted these approvals following rigorous scientific tests. He noted that this is the first time globally that such approval has been granted for a Vitamin D3 drug based on nanotechnology.
You Might Also Like
-
Hyderabad: Hyderabad-based Pulse Pharmaceuticals announced that it has received approval from the...
-
Mumbai: Nifty finally found relief after suffering losses for seven consecutive days. During Thur...
Leave A Comment
Comments